By Sherri Oslick --
About
Court Report: Each week we will report briefly on recently filed
biotech and pharma cases, and a few interesting cases will be selected
for periodic monitoring.
University of Kansas Center for Research, Inc. v. United States of America
2:08-cv-02565; filed November 12, 2008 in the District Court of Kansas
Correction of inventorship of U.S. Patent Nos. 6,713,446 ("Formulation of Boronic Acid Compounds," issued March 30, 2004) and 6,958,319 (same title, issued October 25, 2005), directed to formulations or methods for formulating the drug Velcade®, to add inventors from University of Kansas. View the complaint here.
Orion Corp. v. Sun Pharma Global, Inc.
3:08-cv-05545; filed November 12, 2008 in the District Court of New Jersey
Infringement of U.S. Patent No. 5,446,194 ("Pharmacologically active catechol derivatives," issued August 29, 1995) following a Paragraph IV certification as part of Sun's filing of an ANDA to manufacture a generic version of Orion's Comtan® (entacapone, used in the treatment of Parkinson's Disease). View the complaint here.
Breckenridge Pharmaceutical, Inc. v. Cornerstone Biopharma, Inc. et al.
8:08-cv-02999; filed November 10, 2008 in the District Court of Maryland
Declaratory judgment of invalidity and non-infringement of U.S. Patent Nos. 6,651,816 ("Antihistamine Decongestant Regimens for Treating Rhinitis," issued November 25, 2003) and 6,843,372 (same title, issued January 18, 2005) based on Breckenridge's sale of certain Allergy DN products, products comparable to certain of Cornerstone's AlleRx® formulations (used to treat allergies and symptoms of the common cold). View the complaint here.
Bayer Healthcare LLC v. Norbrook Laboratories Ltd et al.
2:08-cv-00953; filed November 7, 2008 in the Eastern District of Wisconsin
Infringement of U.S. Patent No. 5,756,506 ("Single High Dose Fluoroquinolone Treatment," issued May 26, 1998) following the equivalent of a Paragraph IV certification as part of Norbrook's filing of its ANADA (Abbreviated New Animal Drug Application) to manufacture a generic version of Bayer's BAYTRIL® 100 (enrofloxacin injection, used for the treatment of bovine respiratory disease in beef and non-lactating dairy cattle). View the complaint here. [NB: As reported previously in Court Report, Bayer filed a comparable complaint on November 6, 2008 in the District Court of Kansas.]
Abbott Laboratories et al v. Biovail Laboratories International SRL et al.
6:08-cv-06498; filed November 4, 2008 in the Western District of New York
Infringement of U.S. Patent Nos. 6,277,405 ("Fenofibrate Pharmaceutical Composition Having High Bioavailability and Method for Preparing It," issued August 21, 2001), 7,037,529 (same title, issued May 2, 2006), and 7,041,319 ("Fenofibrate Pharmaceutical Composition Having High Bioavailabilty," issued May 9, 2006) following a Paragraph IV certification as part of Biovail's filing of an ANDA to manufacture a generic version of Abbott's Tricor® (fenofibrate, used in the treatment of increased triglyceride levels). View the complaint here. [NB: As reported reported previously in Court Report, Abbott filed a comparable complaint on November 2, 2008 in the Northern District of Illinios.]
Elan Pharma International Ltd. et al. v. Biovail Laboratories International SRL et al.
2:08-cv-05412; filed November 3, 2008 in the District Court of New Jersey
Infringement of U.S. Patent Nos. 5,145,684 ("Surface Modified Drug Nanoparticles," issued September 8, 1992), 7,276,249 ("Nanoparticulate Fibrate Formulations," issued October 2, 2007), and 7,320,802 ("Methods of Treatment Using Nanoparticulate Fenofibrate Compositions," issued January 22, 2008), all licensed to Abbott, following a Paragraph IV certification as part of Biovail's filing of an ANDA to manufacture a generic version of Abbott's Tricor® (fenofibrate, used in the treatment of increased triglyceride levels). View the complaint here.
Hey Sherri, I just wanted to say that I think this is a great regular feature on Patent Docs. Very useful. Keep it up! Thanks!
Posted by: Pacific Reporter | November 16, 2008 at 11:09 PM